Chemical Works of Gedeon Richter Plc (RGEDF)
43.45
-0.31
(-0.71%)
USD |
OTCM |
Aug 26, 16:00
Chemical Works of Gedeon Richter Debt to Equity Ratio : 0.0141 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0141 |
| March 31, 2026 | 0.0145 |
| December 31, 2025 | 0.0554 |
| September 30, 2025 | 0.0162 |
| June 30, 2025 | 0.0166 |
| March 31, 2025 | 0.0159 |
| December 31, 2024 | 0.0583 |
| September 30, 2024 | 0.0162 |
| June 30, 2024 | 0.0477 |
| March 31, 2024 | 0.0157 |
| December 31, 2023 | 0.0639 |
| September 30, 2023 | 0.0341 |
| June 30, 2023 | 0.0133 |
| March 31, 2023 | 0.0126 |
| December 31, 2022 | 0.0529 |
| September 30, 2022 | 0.016 |
| June 30, 2022 | 0.0198 |
| March 31, 2022 | 0.0179 |
| December 31, 2021 | 0.0189 |
| September 30, 2021 | 0.051 |
| June 30, 2021 | 0.0302 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.018 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.0195 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.0001 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.0432 |
| June 30, 2017 | 0.0478 |
| March 31, 2017 | 0.0482 |
| December 31, 2016 | 0.0542 |
| September 30, 2016 | 0.0582 |
| June 30, 2016 | 0.0646 |
| March 31, 2016 | 0.0676 |
| December 31, 2015 | 0.0709 |
| September 30, 2015 | 0.0833 |
| June 30, 2015 | 0.0854 |
| March 31, 2015 | 0.0953 |
| December 31, 2014 | 0.1051 |
| September 30, 2014 | 0.114 |
| June 30, 2014 | 0.1148 |
| March 31, 2014 | 0.1149 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AstraZeneca PLC | 0.7166 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Avadel Pharmaceuticals Plc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.432B |
| Total Liabilities (Quarterly) | 1.058B |
| Shareholders Equity (Quarterly) | 4.366B |
| Current Ratio | 3.786 |
| Net Debt Paydown Yield | -0.01% |